Literature DB >> 9192776

Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus.

H Groux1, F Cottrez, C Montpellier, B Quatannens, J Coll, D Stehelin, C Auriault.   

Abstract

Epstein-Barr virus (EBV) is a human lymphotropic virus whose main targets have traditionally been described as B lymphocytes and epithelial cells. Here we report the isolation and characterization of largely monoclonal transformed human T-cell lines infected by EBV. The transformed T cells expressed CD2, CD3, and either CD4 or CD8 surface molecules and more generally displayed the phenotype of naive T cells with a complete and clonal rearrangement of the T-cell receptor. None of the cell lines expressed B cells, natural killer, or myeloid antigens or had immunoglobulins genes rearrangement. They grew in the absence of growth factor; however, they all secreted interleukin-2 after mitogenic activation. Polymerase chain reaction (PCR) analysis showed the presence of EBV DNA in all these cell lines. Moreover, Southern blot analysis of one of these cell lines shows the presence of circular episomic EBV DNA, and by Northern blot or reverse transcriptase-PCR analysis, only the expression of Epstein-Barr nuclear antigen-1 (EBNA-1) and latent membrane protein-1 (LMP-1) genes was detected. Finally, the complete transformed phenotype of this T-cell line was shown by its injection into nude or recombination activating gene 2 (RAG2)-deficient mice that led to the formation of solid tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192776

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Herpesvirus saimiri.

Authors:  H Fickenscher; B Fleckenstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

2.  Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.

Authors:  Carrie B Coleman; Eric M Wohlford; Nicholas A Smith; Christine A King; Julie A Ritchie; Paul C Baresel; Hiroshi Kimura; Rosemary Rochford
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

3.  Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.

Authors:  Papa Alioune Ndour; Guillaume Brocqueville; Tan-Sothéa Ouk; Gautier Goormachtigh; Olivier Morales; Alexandra Mougel; Julie Bertout; Oleg Melnyk; Véronique Fafeur; Jean Feuillard; Jean Coll; Eric Adriaenssens
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

4.  Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.

Authors:  Gautier Goormachtigh; Tan-Sothéa Ouk; Alexandra Mougel; Denis Tranchand-Bunel; Eric Masy; Christophe Le Clorennec; Jean Feuillard; Georg W Bornkamm; Claude Auriault; Evelyne Manet; Véronique Fafeur; Eric Adriaenssens; Jean Coll
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.

Authors:  Eric Masy; Eric Adriaenssens; Claire Montpellier; Pascale Crépieux; Alexandra Mougel; Brigitte Quatannens; Gautier Goormachtigh; Nathalie Faumont; Fabienne Meggetto; Claude Auriault; Hervé Groux; Jean Coll
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.

Authors:  N S Rasmussen; A H Draborg; C T Nielsen; S Jacobsen; G Houen
Journal:  Scand J Rheumatol       Date:  2015-01-06       Impact factor: 3.641

7.  Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation.

Authors:  Takuto Ito; Hidetaka Kawazu; Takayuki Murata; Seiko Iwata; Saki Arakawa; Yoshitaka Sato; Kiyotaka Kuzushima; Fumi Goshima; Hiroshi Kimura
Journal:  Cancer Med       Date:  2014-05-03       Impact factor: 4.452

8.  Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients.

Authors:  Anette Holck Draborg; Søren Jacobsen; Marie Westergaard; Shila Mortensen; Janni Lisander Larsen; Gunnar Houen; Karen Duus
Journal:  Lupus Sci Med       Date:  2014-04-01

9.  LMP1-induced cell death may contribute to the emergency of its oncogenic property.

Authors:  Guillaume Brocqueville; Papa Alioune Ndour; Tan-Sothéa Ouk; Arnaud Le Goff; Caroline De Witte; Alexandra Mougel; Jean Coll; Véronique Fafeur; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 10.  Epstein-Barr virus in systemic autoimmune diseases.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2013-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.